학술논문
Triple HER2-blockade with lapatinib, trastuzumab, and pertuzumab for treatment of HER2 positive metastatic breast cancer with lymphangitic carcinomatosis: A case study
Document Type
Author
Source
In Current Problems in Cancer: Case Reports September 2022 7
Subject
Language
ISSN
2666-6219